Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Annamaria Fulop"'
Autor:
Bogdan Fetica, Laura Urian, Ljubomir Petrov, Cosmina Bondor, Cosmina Ioana Gavrilut, Annamaria Fulop
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 23, Iss 4, Pp 483-494 (2015)
The study objective was to examine the clinical and hematological significance of receptor CX3CR1 and megakaryocytes in patients with aplastic anemia. Method. 40 patients diagnosed with aplastic anemia and 10 case-control were included in the study.
Autor:
Ljubomir Petrov, Hans K. Müller-Hermelink, Annamaria Fulop, Florian Nicula, Daniela Coza, Patriciu Achimas-Cadariu, Alexandru Irimie, Dennis D. Weisenburger, Jacques Diebold, Bogdan Pop, Mihaiela L. Blaga, Bharat N. Nathwani, Kenneth A. MacLennan, Anamarija M. Perry, Bogdan Fetica, Delia Dima
Publikováno v:
Hematological Oncology. 35:198-205
Epidemiologic studies of non-Hodgkin lymphoma (NHL) in Eastern Europe are scarce in the literature. We report the experience of the "Ion Chiricuta" Institute of Oncology in Cluj-Napoca (IOCN), Romania, in the diagnosis and outcome of patients with NH
Autor:
Andrea, Onisim, Mihaela, Iancu, Catalin, Vlad, Paul, Kubelac, Bogdan, Fetica, Annamaria, Fulop, Andrei, Achimas-Cadariu, Patriciu, Achimas-Cadariu
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(5)
Pupose: Nestin and CD133 are regarded as putative markers of cancer stem cells (CSCs) and related to poor prognosis in various cancer sites. Since few studies have focused on their role in ovarian cancer, we aimed to investigate their predictive valu
Autor:
Catalin, Vlad, Paul, Kubelac, Andrea, Onisim, Bogdan, Fetica, Annamaria, Fulop, Alexandru, Irimie, Patriciu, Achimas-Cadariu
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
The tumor microenvironment in ovarian cancer (OC) seems to play an important role, and besides tumor cells, biomarkers can derive from endothelial cells. We investigated CDCP1 and ADAM12 expression in relation with other clinical and pathological cha
Autor:
Bogdan, Fetica, Patriciu, Achimas-Cadariu, Bogdan, Pop, Delia, Dima, Ljubomir, Petrov, Anamarija M, Perry, Bharat N, Nathwani, Hans K, Müller-Hermelink, Jacques, Diebold, Kenneth A, MacLennan, Annamaria, Fulop, Mihaiela L, Blaga, Daniela, Coza, Florian Al, Nicula, Alexandru, Irimie, Dennis D, Weisenburger
Publikováno v:
Hematological oncology. 35(2)
Epidemiologic studies of non-Hodgkin lymphoma (NHL) in Eastern Europe are scarce in the literature. We report the experience of the "Ion Chiricuta" Institute of Oncology in Cluj-Napoca (IOCN), Romania, in the diagnosis and outcome of patients with NH
Autor:
Milan-Paul, Kubelac, Bogdan, Fetica, Ioan-Catalin, Vlad, Annamaria, Fulop, Anca, Popa, Patriciu, Achimas-Cadariu
Publikováno v:
Anticancer research. 34(1)
Overexpression of Inhibitor of DNA-binding 1 protein (ID-1) is correlated with poor prognosis in some malignancies and few studies have assessed its role in ovarian cancer. This led us to investigate its association with the microvessel density (MVD)
Autor:
Andrei Cucuianu, Ana-Maria Fit, Ljubomir Petrov, Annamaria Fulop, Luminița Blaga, Bogdan Pop, Delia Dima, Bogdan Fetica
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 22, Iss 4, Pp 497-505 (2014)
Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Among useful markers in identifiyng patients with poor outcome are unmutated IgVH, ZAP-70 and CD38 expression. Both ZAP-70 and CD38 were shown to be capable of identifying aggres